According to global media, Novartis is discussing options with banks for selling its near $14-billion stake in rival Roche, potentially providing cash for new deals. Novartis built up its one-third stake in Roche’s voting stock between 2001 and 2003 under former chairman and CEO Daniel Vasella, as thebasis for a possible merger that never happened. Shares of Novartis India will also remain in focus, though the deal may not materialise immediately.

comment COMMENT NOW